Rufinamide - Epilepsy
You are here : Home > Formulary Search > Rufinamide - Epilepsy
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Amber
Formulations :
- Tablets
Formulary Status :
Restrictions / Comments :
Important
SASH - restricted to paediatrics only.
RSCH - only initiate on recommendation from a tertiary referral centre.
Documentation
Guidelines (National)
PAD Profile
ChemicalSubstance :
Rufinamide
Indication :
Epilepsy
Group Name :
Keywords :
Brand Names Include :
Inovelon
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3
Traffic Light Entries :
2
Other Indications
Below are listed other indications that Rufinamide is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Epilepsy.
- Brivaracetam
- Cannabis (medicinal)
- Carbamazepine
- Cenobamate
- Clobazam
- Clonazepam
- Eslicarbazepine acetate
- Ethosuximide
- Gabapentin
- Lacosamide
- Lamotrigine
- Levetiracetam
- Oxcarbazepine
- Perampanel
- Phenobarbital
- Phenytoin
- Pregabalin
- Primidone
- Sodium valproate (NON childbearing potential)
- Sodium valproate (with childbearing potential)
- Stiripentol
- Sulthiame
- Tiagabine
- Topiramate
- Vigabatrin
- Zonisamide
Committee Recommendations (1)
The PCN supported the principles of switching from brand to generic medications (not recommended in the elderly) as per national guidelines in September 2013 and the proposed place in therapy of the anti-epileptic drugs which is based on NICE guidance was also discussed at that time. Transfer of care documents will be considered at a future PCN.
Please note the MHRA categorisations for each drug in the attached guidance (updated January 2014) and in the link below.
Please note the MHRA categorisations for each drug in the attached guidance (updated January 2014) and in the link below.